199 related articles for article (PubMed ID: 22491052)
1. Hypogonadism and infertility in testicular cancer survivors.
Jacobs LA; Vaughn DJ
J Natl Compr Canc Netw; 2012 Apr; 10(4):558-63. PubMed ID: 22491052
[TBL] [Abstract][Full Text] [Related]
2. Hypogonadism and fertility issues following primary treatment for testicular cancer.
Oldenburg J
Urol Oncol; 2015 Sep; 33(9):407-12. PubMed ID: 25736189
[TBL] [Abstract][Full Text] [Related]
3. High risk of hypogonadism in young male cancer survivors.
Isaksson S; Bogefors K; Ståhl O; Eberhard J; Giwercman YL; Leijonhufvud I; Link K; Øra I; Romerius P; Bobjer J; Giwercman A
Clin Endocrinol (Oxf); 2018 Mar; 88(3):432-441. PubMed ID: 29245176
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of hypogonadism determined by serum free testosterone level in Japanese testicular cancer survivors.
Kurobe M; Kawai K; Suetomi T; Iwamoto T; Waku N; Kawahara T; Kojima T; Joraku A; Miyazaki J; Nishiyama H
Int J Urol; 2018 May; 25(5):457-462. PubMed ID: 29478250
[TBL] [Abstract][Full Text] [Related]
5. Hypogonadism and androgen deficiency symptoms in testicular cancer survivors.
Lackner JE; Märk I; Schatzl G; Marberger M; Kratzik C
Urology; 2007 Apr; 69(4):754-8. PubMed ID: 17445664
[TBL] [Abstract][Full Text] [Related]
6. Hypergonadotrophic hypogonadism due to testicular adrenal rest tumours presenting with hypogonadotrophic hypergonadism.
Ashby HL; Gama RM; Sur H; Inglis J; Ford C; Gama R
Ann Clin Biochem; 2012 Sep; 49(Pt 5):497-9. PubMed ID: 22734073
[TBL] [Abstract][Full Text] [Related]
7. Delayed treatment of undescended testes may promote hypogonadism and infertility.
Rohayem J; Luberto A; Nieschlag E; Zitzmann M; Kliesch S
Endocrine; 2017 Mar; 55(3):914-924. PubMed ID: 28070708
[TBL] [Abstract][Full Text] [Related]
8. Testicular Cancer Survivorship and Fertility Preservation.
Tverye A; Nangia A; Fantus RJ
Urol Clin North Am; 2024 Aug; 51(3):429-438. PubMed ID: 38925745
[TBL] [Abstract][Full Text] [Related]
9. Risk of low bone mineral density in testicular germ cell cancer survivors: association with hypogonadism and treatment modality.
Isaksson S; Bogefors K; Åkesson K; Egund L; Bobjer J; Leijonhufvud I; Giwercman A
Andrology; 2017 Sep; 5(5):898-904. PubMed ID: 28591464
[TBL] [Abstract][Full Text] [Related]
10. Hypogonadism risk in men treated for childhood cancer.
Romerius P; Ståhl O; Moëll C; Relander T; Cavallin-Ståhl E; Wiebe T; Giwercman YL; Giwercman A
J Clin Endocrinol Metab; 2009 Nov; 94(11):4180-6. PubMed ID: 19789207
[TBL] [Abstract][Full Text] [Related]
11. Gonadal dysfunction and fertility problems in cancer survivors.
Brydøy M; Fosså SD; Dahl O; Bjøro T
Acta Oncol; 2007; 46(4):480-9. PubMed ID: 17497315
[TBL] [Abstract][Full Text] [Related]
12. Long-term medical care of testicular cancer survivors.
Vaughn DJ; Gignac GA; Meadows AT
Ann Intern Med; 2002 Mar; 136(6):463-70. PubMed ID: 11900499
[TBL] [Abstract][Full Text] [Related]
13. [Hypogonadism in patients with testicular tumors and prostate cancer].
Radko M; Syryło T; Zieliński H
Wiad Lek; 2017; 70(1):81-84. PubMed ID: 28343199
[TBL] [Abstract][Full Text] [Related]
14. Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors.
Abu Zaid M; Dinh PC; Monahan PO; Fung C; El-Charif O; Feldman DR; Hamilton RJ; Vaughn DJ; Beard CJ; Cook R; Althouse S; Ardeshir-Rouhani-Fard S; Sesso HD; Huddart R; Mushiroda T; Kubo M; Dolan ME; Einhorn LH; Fossa SD; Travis LB;
J Natl Compr Canc Netw; 2019 May; 17(5):459-468. PubMed ID: 31085753
[TBL] [Abstract][Full Text] [Related]
15. Reproductive hormones and metabolic syndrome in 24 testicular cancer survivors and their biological brothers.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
Andrology; 2017 Jul; 5(4):718-724. PubMed ID: 28598554
[TBL] [Abstract][Full Text] [Related]
16. Infertility and testis cancer.
Lambert SM; Fisch H
Urol Clin North Am; 2007 May; 34(2):269-77; abstract xi. PubMed ID: 17484932
[TBL] [Abstract][Full Text] [Related]
17. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O;
Eur Urol; 2010 Jul; 58(1):134-40. PubMed ID: 20395037
[TBL] [Abstract][Full Text] [Related]
18. Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors.
Ekedahl H; Isaksson S; Ståhl O; Bogefors K; Romerius P; Eberhard J; Giwercman A
BMC Cancer; 2022 Feb; 22(1):157. PubMed ID: 35135482
[TBL] [Abstract][Full Text] [Related]
19. Testicular cancer survivorship: research strategies and recommendations.
Travis LB; Beard C; Allan JM; Dahl AA; Feldman DR; Oldenburg J; Daugaard G; Kelly JL; Dolan ME; Hannigan R; Constine LS; Oeffinger KC; Okunieff P; Armstrong G; Wiljer D; Miller RC; Gietema JA; van Leeuwen FE; Williams JP; Nichols CR; Einhorn LH; Fossa SD
J Natl Cancer Inst; 2010 Aug; 102(15):1114-30. PubMed ID: 20585105
[TBL] [Abstract][Full Text] [Related]
20. Quality of Life in Long-Term Testicular Cancer Survivors With Compensated Leydig Cell Dysfunction.
Skøtt JW; Lauritsen J; Kreiberg M; Daugaard G; Bandak M
Clin Genitourin Cancer; 2019 Feb; 17(1):e65-e71. PubMed ID: 30293923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
